MedPath

Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.

Phase 4
Completed
Conditions
Contrast Induced Nephropathy
Interventions
Registration Number
NCT00639912
Lead Sponsor
Arcispedale Santa Maria Nuova-IRCCS
Brief Summary

The aim of the study is to test the efficacy of low versus high volume hydration and two different solutions (sodium chloride versus sodium bicarbonate) in preventing contrast induced nephropathy (CIN) in ST elevation myocardial infarction (STEMI) patients undergoing primary PCI.

Detailed Description

Contrast-induced nephropathy (CIN) is associated with increased morbidity and mortality after percutaneous coronary interventions (PCI). Patients with ST elevation myocardial infarction (STEMI) are at high risk for CIN because of hemodynamic instability of the patient, inability to prevent the phenomenon (hydration) and the possible exposure to high volume of contrast media. Recent reports have shown incidence of CIN up to 19% in this population and a related increase of in-hospital mortality.

Merten e coll. (JAMA 2004) reported that sodium bicarbonate infusion before and after contrast exposure in patients with chronic renal failure and without myocardial infarction (AMI) is more effective than sodium chloride in preventing CIN.

Up to date there is no evidence of any effective prophylactic measures in patients with STEMI undergoing primary PCI.

The aim of the study is to test the efficacy of low versus high volume hydration and the efficacy of two different solutions (sodium chloride versus sodium bicarbonate) in preventing CIN in STEMI patients undergoing primary PCI.

The infusion of the randomized solution will start just after randomization and after determination of baseline serum creatinine.

Determination of serum creatinine will be repeated at 24, 48 and 72 hours after randomization. Creatinine clearance will be calculated with Cockroft-Gault formula and MDRD.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
599
Inclusion Criteria
  • Age > 18 years of years
  • Chest pain lasting at least 30 minutes, non responsive to nitrates, associated to ST elevation of at least 0.2 mV on surface ECG in two or more contiguous leads or to new left bundle branch block.
  • Informed consent
Exclusion Criteria
  • Chronic hemodialytic or peritoneal treatment
  • Coronary anatomy unsuitable for PCI
  • Need of emergency coronary artery by-pass grafting
  • Post-anoxic coma
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
A: low volume salinesodium chlorideSolution of 154 mEq/L of sodium chloride. Rate of infusion: 1 ml/kg/hour for 12 hours after the procedure, starting in the Cath Lab.
B: high volume salinesodium chlorideSolution of 154 mEq/L of sodium chloride. Rate of infusion: 3 ml/Kg for 1 hour, followed by 1 ml/Kg/hour for 12 hours after the procedure, starting in the Cath lab.
C: low volume sodium bicarbonatesodium bicarbonateSolution of 154 mEq/L of sodium bicarbonate. Rate of infusion: 1 ml/Kg/hour for 12 hours after the procedure, starting in the Cath Lab.
D: high volume sodium bicarbonatesodium bicarbonateSolution of 154 mEq/L of sodium bicarbonate. Rate of infusion: 3 ml/Kg for 1 hour, followed by 1 ml/Kg/hour for 12 hours after the procedure, starting in the Cath Lab.
Primary Outcome Measures
NameTimeMethod
contrast induced nephropathy incidence24, 48 and 72 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Arcispedale S. Maria Nuova

๐Ÿ‡ฎ๐Ÿ‡น

Reggio Emilia, Emilia-Romagna, Italy

Dipartimento di Cardiologia, Ospedale di Lavagna

๐Ÿ‡ฎ๐Ÿ‡น

Lavagna, Genova, Italy

Azienda Ospedaliera Universitaria S. Anna

๐Ÿ‡ฎ๐Ÿ‡น

Ferrara, Emilia-romagna, Italy

Dipartimento di Cardiologia, Ospedale Maggiore

๐Ÿ‡ฎ๐Ÿ‡น

Parma, Italy

Nuovo Ospedale Civile di Baggiovara

๐Ÿ‡ฎ๐Ÿ‡น

Modena, Emilia-Romagna, Italy

ยฉ Copyright 2025. All Rights Reserved by MedPath